1. Introduction
lianbang Hyperbaric Oxygen Therapy (HBOT) is a safe, effective auxiliary rehabilitation solution for diabetes management. It cannot replace prescription medication, insulin, diet or exercise therapy. By delivering high-pressure and high-concentration oxygen to the body, the lianbang hyperbaric oxygen chamber improves tissue hypoxia, microcirculation disorders and chronic inflammation, helping stabilize blood sugar and alleviate diabetic complications.
2. Core Mechanism for Diabetes Improvement
Adopting a medical standard pressure of 1.6–3.0 ATA, lianbang HBOT targets the root causes of type 2 diabetes: insulin resistance and tissue hypoxia, optimizing glucose metabolism efficiently.
Improve Insulin Sensitivity: Boosts mitochondrial oxygen supply, upregulates GLUT4 expression, enhances blood glucose utilization, reduces insulin resistance, and stabilizes fasting blood sugar and HbA1c levels.
Optimize Metabolic Function: Restores normal aerobic metabolism, reduces lactic acid accumulation, and relieves fatigue caused by diabetic metabolic disorders.
Improve Microcirculation: Lowers blood viscosity, inhibits platelet aggregation, unblocks peripheral microvessels, and prevents long-term vascular damage from hyperglycemia.
Reduce Chronic Inflammation: Lowers inflammatory factors (TNF-α, IL-6), relieves systemic low-grade inflammation, and protects pancreatic and vascular endothelial cells.
3. Key Benefits for Diabetic Complications
3.1 Diabetic Foot
As the most clinically verified application, HBOT elevates foot tissue oxygen partial pressure, improves local ischemia and hypoxia, promotes angiogenesis and wound granulation repair. It accelerates ulcer healing, controls refractory infections and tissue necrosis, and effectively lowers amputation risk. The standard protocol is 2.0–2.5 ATA for 20–30 sessions.
3.2 Diabetic Peripheral Neuropathy
HBOT repairs damaged nerve myelin, accelerates nerve conduction, and boosts nerve growth factor secretion, significantly relieving typical symptoms including numbness, tingling, burning pain and cold limbs.
3.3 Diabetic Retinopathy
It alleviates retinal edema and hypoxia, inhibits abnormal neovascularization, and delays the progression of non-proliferative diabetic retinopathy. Professional ophthalmic evaluation is required for patients with proliferative fundus hemorrhage before treatment.
3.4 Other Auxiliary Benefits
Improves renal microcirculation to reduce microalbuminuria in early diabetic nephropathy, enhances skin antibacterial ability to cure refractory wounds, and improves diabetic sexual dysfunction by repairing pelvic blood supply.
4. Core Working Principles of HBOT
High-efficiency Oxygen Supply: Increases plasma dissolved oxygen by 10–20 times, oxygenating ischemic tissues independent of hemoglobin.
Microvascular Repair & Regeneration: Stimulates NO release, dilates blood vessels and builds collateral circulation.
Cell Protection & Repair: Activates cellular metabolism to protect pancreas, blood vessel and nerve cells.
Block Disease Vicious Cycle: Combines anti-inflammatory, anticoagulant and repair effects to stop hypoxia-induced diabetic lesion progression.
5. Safety Precautions
Auxiliary Use Only: Do not stop or reduce diabetes medication or insulin without professional medical guidance.
Blood Sugar Monitoring: Avoid empty-stomach treatment to prevent hypoglycemia caused by temporary blood sugar drop after HBOT.
Contraindications: Not suitable for patients with uncontrolled severe hypertension, pneumothorax, severe COPD, untreated fundus hemorrhage and severe claustrophobia.
Standard Treatment Course: 20–30 sessions (90 minutes each) are required for stable rehabilitation effects.
Medical-grade Advantage: lianbang ≥1.6 ATA medical hyperbaric chambers deliver far better effects than household low-pressure oxygen chambers for diabetic complications.
6. Suitable Users
Type 2 diabetes patients with insulin resistance and unstable blood sugar
Patients with diabetic foot ulcers, unhealed wounds and tissue necrosis
People with diabetic peripheral neuropathy (numbness, pain, cold limbs)
Patients with early diabetic retinal and renal microvascular lesions
Diabetic patients with refractory postoperative wounds and recurring skin infections